Vineet Laboratories Limited

NSE: VINEETLAB · Unclassified

₹37.04-0.11%06 Nov 2026

Ask the data

Instant answers about Vineet Laboratories Limited — computed from its filings, no language model

Market cap₹71 cr

Current price₹37.04

High / Low₹48 / ₹29

P/E17.9

P/B1.56

Book value₹23.7

ROE8.7%

ROCE9.0%

Debt / equity0.99

Dividend yield—

EPS (TTM)₹2.07

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	243.5	191.2	212.3	150.6	75.0	59.4
EBITDA	8.2	13.2	7.7	7.2	-16.3	8.5
Operating margin	3.3%	6.9%	3.6%	4.8%	-21.7%	14.3%
Interest	2.7	2.2	3.4	4.8	4.0	4.9
Depreciation	1.8	2.0	2.4	2.5	2.5	2.4
Profit before tax	4.1	9.3	2.0	0.4	-20.8	1.3
Tax	2.3	2.7	0.8	-0.7	-0.6	0.2
Net profit	1.8	6.6	1.2	1.0	-20.2	1.6
EPS ₹	2.18	7.16	1.36	1.11	-21.90	1.00
Operating cash flow	—	7.7	-9.6	-11.4	11.5	-12.2
Capex	—	3.7	7.6	0.2	1.1	1.2
Dividend paid	—	0.0	0.9	0.0	0.0	0.0
Total assets	—	—	115.8	116.9	94.5	124.8
Equity	—	—	33.7	34.7	14.7	45.6

Quarterly performance

last 21 quarters · ₹ crore

showing latest 8 of 21 periods

	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
Revenue	243.5	57.7	39.5	38.4	55.6	39.5	66.8	57.2	37.5	43.4	32.6	37.0	23.9	19.0	18.1	14.1	7.4	17.4	15.7	18.9	10.4
Operating profit	8.2	2.7	1.8	2.6	6.1	-4.0	1.9	5.8	0.3	4.2	-0.6	3.4	-0.8	-0.3	-4.1	-11.1	0.3	3.2	2.5	2.5	2.2
Operating margin	3.3%	4.7%	4.6%	6.9%	10.9%	-10.1%	2.9%	10.2%	0.7%	9.6%	-2.0%	9.2%	-3.4%	-1.6%	-22.9%	-78.5%	4.3%	18.3%	15.9%	13.2%	21.7%
Other income	0.4	0.0	0.2	-0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.0	1.4	0.0	0.0	0.1	0.0	0.1
Interest	2.7	0.5	0.5	0.3	0.8	0.6	1.0	0.4	1.0	1.0	1.1	1.7	1.1	1.0	0.9	0.9	0.6	2.2	1.1	1.0	1.0
Depreciation	1.8	0.5	0.5	0.5	0.5	0.7	0.5	0.6	0.6	0.6	0.6	0.7	0.6	0.6	0.6	0.7	0.6	0.6	0.6	0.5	0.6
Profit before tax	4.1	1.7	1.0	1.8	4.9	-5.3	0.4	4.8	-1.3	2.5	-2.3	1.4	-2.2	-1.7	-5.7	-11.2	-0.9	0.4	0.8	1.0	0.8
Tax	2.3	0.5	0.2	0.4	1.6	-0.6	-1.0	1.3	-0.0	0.1	-0.3	-0.5	-0.0	0.1	0.0	-0.7	-0.0	-0.0	-0.0	0.3	-0.7
Net profit	1.8	1.3	0.7	1.4	3.3	-4.7	1.4	3.5	-1.2	2.4	-2.1	1.9	-2.1	-1.8	-5.7	-10.5	-0.9	0.4	0.8	1.2	1.5
EPS ₹	2.18	1.38	0.78	7.38	3.60	-5.10	1.51	3.85	-1.36	2.62	-2.24	2.09	-2.31	-1.98	-6.19	-11.42	-0.94	0.43	0.92	0.43	0.73
Revenue YoY	—	—	—	—	-77.2%	-0.1%	74.0%	2.9%	—	9.8%	-51.1%	-35.2%	-36.4%	-56.3%	-44.6%	-62.0%	-68.8%	-8.1%	-13.5%	34.2%	39.7%
Profit YoY	—	—	—	—	84.3%	-752.8%	2.2%	8.2%	—	—	-248.9%	-45.9%	—	-175.6%	—	-648.4%	—	—	—	—	—

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 15 periods

	DEC '21	MAR '22	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26
ROE	—	—	-3.0%	17.5%	7.6%	2.9%	0.4%	-13.4%	-25.2%	-137.9%	-129.3%	-117.5%	-71.4%	3.5%	8.7%
ROCE	—	—	2.5%	13.1%	9.6%	6.5%	5.6%	0.2%	-4.7%	-30.7%	-29.3%	-22.4%	-10.8%	6.8%	9.0%
Net margin	1.4%	3.5%	-0.5%	3.0%	1.6%	0.7%	0.1%	-3.7%	-7.9%	-26.9%	-32.3%	-29.3%	-18.6%	2.7%	6.4%
EBITDA margin	4.0%	6.9%	2.0%	6.0%	5.6%	4.8%	4.5%	1.5%	-1.9%	-21.7%	-25.9%	-20.5%	-9.3%	14.3%	16.7%
Debt / equity	—	—	0.92	1.17	1.17	1.28	1.28	1.32	1.32	2.73	2.73	3.01	3.01	0.99	0.99
Interest coverage	3.11	5.31	0.55	2.93	2.10	1.08	0.89	0.03	-0.69	-4.22	-4.65	-2.75	-1.28	1.26	1.57
Asset turnover	—	—	1.73	1.68	1.40	1.29	1.17	1.06	0.92	0.79	0.62	0.63	0.60	0.48	0.50

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26
Share capital	9.2	9.2	9.2	9.2	9.2	9.2	9.2	19.2
Other equity / reserves	20.3	24.5	25.6	25.5	21.6	5.4	5.0	26.4
Total equity	29.5	33.7	34.9	34.7	30.8	14.7	14.2	45.6
Borrowings	30.9	31.1	40.6	44.3	40.6	40.0	42.8	45.3
Current liabilities	76.1	74.5	80.0	76.0	68.2	74.4	67.9	67.3
Non-current liabilities	10.4	7.7	7.2	6.2	7.6	5.5	8.5	11.9
Total assets	116.1	115.8	122.0	116.9	106.5	94.5	90.6	124.8
Property, plant & equipment	25.0	26.6	26.2	26.9	26.4	25.5	24.2	24.2
Capital work-in-progress	—	0.0	—	—	0.0	—	0.0	0.0
Investments	0.1	0.1	0.0	0.2	0.2	0.2	0.2	0.2
Inventories	49.9	46.2	43.5	49.4	51.0	50.0	56.7	64.1
Receivables	28.9	35.2	46.6	31.6	22.6	13.2	4.3	11.4
Cash & equivalents	3.3	0.6	0.6	0.2	0.1	0.3	0.3	16.7

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	7.7	-9.6	-11.4	11.5	-12.2
Cash from investing	-3.6	-6.7	0.3	-3.2	-1.1
Cash from financing	11.9	0.3	10.7	-8.2	29.7
Capex	3.7	7.6	0.2	1.1	1.2
Free cash flow	4.0	-17.2	-11.7	10.4	-13.4
Dividends paid	0.0	0.9	0.0	0.0	0.0

Where the assets sit

Mar '26 · ₹ crore

Fixed assets (PPE)

₹24.2 cr19%

Investments

₹0.2 cr0%

Inventories

₹64.1 cr51%

Receivables

₹11.4 cr9%

Cash & equivalents

₹16.7 cr13%

Other assets

₹8.2 cr7%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Vineet Laboratories Limited	71	37.04	17.9	1.56	8.7%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+1.1%

6 months-6.4%

1 year-19.5%

3Y CAGR-11.2%

5Y CAGR-14.8%

10Y CAGR—

50-day avg₹37.00

200-day avg₹34.93

RSI (14)41

FAQs

What is the share price of Vineet Laboratories Limited?

Vineet Laboratories Limited (VINEETLAB) closed at ₹37.04 on NSE on 06 Nov 2026.

What is the market cap of Vineet Laboratories Limited?

₹71 crore at the latest close.

What is the P/E ratio of Vineet Laboratories Limited?

17.9, on trailing-twelve-month earnings from its filings.

How fast is Vineet Laboratories Limited growing?

Vineet Laboratories Limited: revenue has compounded at -34.6% a year over three years; net profit at 8.6% a year. Latest-quarter revenue is up 39.7% year on year.

How profitable is Vineet Laboratories Limited?

On a trailing-twelve-month basis return on equity is 8.7%, return on capital employed 9.0%, operating margin 16.7%, net margin 6.4%.

How much debt does Vineet Laboratories Limited have?

Vineet Laboratories Limited is moderately geared: debt to equity is 0.99 with borrowings of ₹45 cr against cash of ₹17 cr (balance sheet of 2026-03-31). Operating profit covers interest 1.6 times.

Financials parsed from Vineet Laboratories Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from MAR '21, annual from FY21, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.